Editorial [A Novel Immunobiological Drugs in Dermatology (Guest Editor: Neslihan Sendur)]

Biologic agents are becoming more important in dermatology in recent years due to their success in treating some skin diseases resistant to other medical therapies. In a few studies, they have been found effective in increasing the quality of life of psoriatic patients by removing the physical and social restrictions of the disease. Though costly and difficult to prescribe, they are used more in dermatology as other rheumatic diseases. In this issue, after a brief introduction of biologic drugs used in dermatology, their mechanism of action, dermatologic indications and side effects will be discussed. Also, the advantages and disadvantages of different biologic drugs will be compared in light of recent literature. New indications for use as well as the side effects of these drugs will lead us to consider the extent of their usage in this field. As far as possible, the authors of this issue have collected recent data from several random controlled studies. I hope this review will guide readers in the appropriate use of biologics and answer most questions concerning these new agents.